Additionally, in vivo and in vitro resistance to sorafenib in hepatocellular carcinoma cell lines was induced by the EV-mediated delivery of HGF and subsequent HGF/c-MET/PI3K/AKT signaling pathway activation, a major oncogenic signaling axis involved in cancer cell proliferation and survival [176]. This evidence concerns the gene HGF and hepatocellular carcinoma.